A 2021 review published in Nutrients found that GLP-1 receptor agonist use was associated with reduced dietary intake of multiple micronutrients including B12, particularly in patients following calorie-restricted eating patterns, supporting the rationale for monitoring B12 status during treatment even in patients without pre-existing deficiency risk factors
The decision to avoid these products should be individualized based on comprehensive medical history and current health status
Disclaimer: At BFH, we strive to keep all contentarticles, press releases, dataas accurate and current as possible at time of publishing
Though rare, some patients using GLP-1 medications have reported eye-related issues, including: Blurred Vision: GLP-1 drugs can impact blood sugar levels, and fluctuations in blood sugar can temporarily cause blurred vision
Stress and Obesity: Are There More Susceptible Individuals
But lip tissue presents unique challenges